Treatment with MG132 significantly increased IRS2 levels but not IRS1 levels in HepG2 and SMMC-7721 cells treated without AFB1, indicating that IRS2 might undergo proteasomal degradation in AFB1-untreated hepatoma cells. Here, IRS2 is linked to hepatocellular carcinoma.